Early research (Phase 1)Study completedNCT02037074
What this trial is testing
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics
Who this might be right for
Schizophrenia
FORUM Pharmaceuticals Inc 40